UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of the Biopharmaceutical Classification System in Early Drug Development

The AAPS journal, 2008-03, Vol.10 (1), p.208-212

Ku, M. Sherry

2008

Volltextzugriff (PDF)

A biopharmaceutical classification-based Right-First-Time formulation approach to reduce human pharmacokinetic variability and project cycle time from First-In-Human to clinical Proof-Of-Concept

Pharmaceutical development and technology, 2012-05, Vol.17 (3), p.285-302

2012

Volltextzugriff (PDF)

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance

Journal of pharmaceutical sciences, 2011-10, Vol.100 (10), p.4090-4110

2011

Volltextzugriff (PDF)

PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the physiologically‐based pharmacokinetic modeling approach

Journal of pharmaceutical sciences, 2011-10, Vol.100 (10), p.4127-4157

2011

Volltextzugriff (PDF)

Performance qualification of a new hypromellose capsule: Part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus ®, Quali-V ® and gelatin capsules

International journal of pharmaceutics, 2010-02, Vol.386 (1), p.30-41

2010

Volltextzugriff (PDF)

Prediction of drug particle size and content uniformity in low-dose solid dosage forms

International journal of pharmaceutics, 2010-01, Vol.383 (1), p.70-80

2010

Volltextzugriff (PDF)

PhRMA CPCDC Initiative on Predictive Models of Human Pharmacokinetics, Part 1: Goals, Properties of the Phrma Dataset, and Comparison with Literature Datasets

Journal of pharmaceutical sciences, 2011-10, Vol.100 (10), p.4050-4073

2011

Volltextzugriff (PDF)

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: Prediction of plasma concentration–time profiles in human from in vivo preclinical data by using the Wajima approach

Journal of pharmaceutical sciences, 2011-10, Vol.100 (10), p.4111-4126

2011

Volltextzugriff (PDF)

Solid dispersion of acetaminophen and poly(ethylene oxide) prepared by hot-melt mixing

International journal of pharmaceutics, 2010-08, Vol.395 (1), p.53-61

2010

Volltextzugriff (PDF)

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: Comparative assessment of prediction methods of human volume of distribution

Journal of pharmaceutical sciences, 2011-10, Vol.100 (10), p.4074-4089

2011

Volltextzugriff (PDF)

Asymmetry Effect of Particle Size Distribution on Content Uniformity and Over-Potency Risk in Low-Dose Solid Drugs

Journal of pharmaceutical sciences, 2010-10, Vol.99 (10), p.4351-4362

2010

Volltextzugriff (PDF)

Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules

International journal of pharmaceutics, 2011-09, Vol.416 (1), p.16-24

2011

Volltextzugriff (PDF)

Discovery of ecopladib, an indole inhibitor of cytosolic phospholipase A2α

Journal of medicinal chemistry, 2007-03, Vol.50 (6), p.1380-1400

2007

Volltextzugriff (PDF)

Discovery of Ecopladib, an Indole Inhibitor of Cytosolic Phospholipase Α2α

Journal of medicinal chemistry, 2007-03, Vol.50 (6), p.1380-1400

2007

Volltextzugriff (PDF)

Discovery of Ecopladib, an indole inhibitor of cytosolic phospholipase A2alpha

Journal of medicinal chemistry, 2007-03, Vol.50 (6), p.1380-1400

2007

Volltextzugriff (PDF)

Discovery of Ecopladib, an Indole Inhibitor of Cytosolic Phospholipase Α 2 α

Journal of medicinal chemistry, 2007-03, Vol.50 (6), p.1380-1400

2007

Volltextzugriff (PDF)

Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective Study

Radiology, 2021-06, Vol.299 (3), p.203935-547

2021

Volltextzugriff (PDF)

Effect of Mammography Screening on Mortality by Histological Grade

Cancer epidemiology, biomarkers & prevention, 2018-02, Vol.27 (2), p.154-157

2018

Volltextzugriff (PDF)

Competitive Activity-Based Protein Profiling Identifies Aza-β-Lactams as a Versatile Chemotype for Serine Hydrolase Inhibition

Journal of the American Chemical Society, 2012-03, Vol.134 (11), p.5068-5071

2012

Volltextzugriff (PDF)

Selective Inhibitor of Platelet-Activating Factor Acetylhydrolases 1b2 and 1b3 That Impairs Cancer Cell Survival

ACS chemical biology, 2015-04, Vol.10 (4), p.925-932

2015

Volltextzugriff (PDF)

CPF: An Orphan Nuclear Receptor That Regulates Liver-Specific Expression of the Human Cholesterol 7α -Hydroxylase Gene

Proceedings of the National Academy of Sciences - PNAS, 1999-06, Vol.96 (12), p.6660-6665

1999

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(29)
Bücher
(3)

Sprache

Englisch
(31)
Japanisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Use of the Biopharmaceutical Classification System in Early Drug Development

A biopharmaceutical classification-based Right-First-Time formulation approach to reduce human pharmacokinetic variability and project cycle time from First-In-Human to clinical Proof-Of-Concept

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance

PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the physiologically‐based pharmacokinetic modeling approach

Performance qualification of a new hypromellose capsule: Part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus ®, Quali-V ® and gelatin capsules

Prediction of drug particle size and content uniformity in low-dose solid dosage forms

PhRMA CPCDC Initiative on Predictive Models of Human Pharmacokinetics, Part 1: Goals, Properties of the Phrma Dataset, and Comparison with Literature Datasets

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: Prediction of plasma concentration–time profiles in human from in vivo preclinical data by using the Wajima approach

Solid dispersion of acetaminophen and poly(ethylene oxide) prepared by hot-melt mixing

PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: Comparative assessment of prediction methods of human volume of distribution

Asymmetry Effect of Particle Size Distribution on Content Uniformity and Over-Potency Risk in Low-Dose Solid Drugs

Performance qualification of a new hypromellose capsule: Part II. Disintegration and dissolution comparison between two types of hypromellose capsules

Indole Cytosolic Phospholipase A2 α Inhibitors: Discovery and in Vitro and in Vivo Characterization of 4-{3-[5-Chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic Acid, Efipladib

Discovery of ecopladib, an indole inhibitor of cytosolic phospholipase A2α

Discovery of Ecopladib, an Indole Inhibitor of Cytosolic Phospholipase Α2α

Indole Cytosolic Phospholipase A 2 α Inhibitors: Discovery and in Vitro and in Vivo Characterization of 4-{3-[5-Chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1 H -indol-3-yl]propyl}benzoic Acid, Efipladib

Discovery of Ecopladib, an indole inhibitor of cytosolic phospholipase A2alpha

Discovery of Ecopladib, an Indole Inhibitor of Cytosolic Phospholipase Α 2 α

Indole Cytosolic Phospholipase A2 α Inhibitors : Discovery and in Vitro and in Vivo Characterization of 4-{3-[5-Chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-l-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic Acid, Efipladib

Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women

Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective Study

Effect of Mammography Screening on Mortality by Histological Grade

Competitive Activity-Based Protein Profiling Identifies Aza-β-Lactams as a Versatile Chemotype for Serine Hydrolase Inhibition

Selective Inhibitor of Platelet-Activating Factor Acetylhydrolases 1b2 and 1b3 That Impairs Cancer Cell Survival

CPF: An Orphan Nuclear Receptor That Regulates Liver-Specific Expression of the Human Cholesterol 7α -Hydroxylase Gene

Suchergebnisse filtern